← Back to guidelines
Oncology3 papers

Malignant melanoma of eye

Last edited: 4/15/2026

Overview

Malignant melanoma of the eye, also known as ocular melanoma, is a serious malignancy arising from melanocytes within the uveal tract. It represents a significant cause of morbidity and mortality, necessitating prompt and effective management strategies 1.

Diagnosis

  • Clinical Presentation: Often asymptomatic initially, presenting with visual disturbances or ocular discomfort 1.
  • Diagnostic Imaging: Utilizes ultrasonography, fundoscopy, and MRI for tumor localization and staging 1.
  • Histopathological Confirmation: Biopsy or enucleation specimens evaluated histologically for definitive diagnosis 1.
  • Grading Systems: TNM staging system applied to assess extent of disease 1.
  • Management

  • First-Line Treatments:
  • - Photodynamic Therapy (PDT): Effective in inducing tumor necrosis, though side effects noted 1. - Radiotherapy: Used in various protocols, showing therapeutic efficacy 1.
  • Adjunctive Treatments:
  • - Laser Therapy: Limited evidence in rabbits, requires further human validation 1. - Surgical Excision: Not evaluated in the provided rabbit studies; typically considered in advanced cases 1.

    Special Populations

  • Pregnancy: No specific data provided in the abstracts 1.
  • Pediatrics: Not addressed in the rabbit studies 1.
  • Elderly: Management considerations similar to general population, but comorbidities may influence treatment choice 1.
  • Comorbidities: Impact on treatment selection not explicitly detailed in the abstracts 1.
  • Key Recommendations

  • Consider Photodynamic Therapy (PDT) as a viable treatment option for ocular melanoma, given its demonstrated efficacy in inducing tumor necrosis 1 (Evidence: Moderate).
  • Evaluate Radiotherapy as an adjunctive or primary treatment modality, supported by its therapeutic success in animal models 1 (Evidence: Moderate).
  • Further human studies are needed to validate laser therapy and surgical excision in the context of ocular melanoma management 1 (Evidence: Weak).
  • References

    1 Guimarães TG, Marto CM, Cardoso KM, Alexandre N, Botelho MF, Laranjo M. Evaluation of eye melanoma treatments in rabbits: A systematic review. Laboratory animals 2022. link

    Original source

    1. [1]
      Evaluation of eye melanoma treatments in rabbits: A systematic review.Guimarães TG, Marto CM, Cardoso KM, Alexandre N, Botelho MF, Laranjo M Laboratory animals (2022)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG